SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $137.1 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of $1.45 per share.
The results fell short of Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.
The biopharmaceutical company posted revenue of $2 million in the period, also missing Street forecasts. Six analysts surveyed by Zacks expected $7.5 million.
For the year, the company reported that its loss widened to $389 million, or $4.33 per share. Revenue was reported as $94.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CYTK">Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK